Summary of the CAPTIVATE platform which will be a twitter spaces discussion
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
This week, we will discuss a pediatric nephrology trial: is tacrolimus superior to MMF in FRNS and SDNS?
This week, we will discuss a NEJM trial on uncontrolled hypertension: lorundrostat, an aldosterone synthase inhibitor, aims at the hormonal dark side driving resistance.
The full filtrate met last week to chat up CREDENCE. Hear the podcast on the web, or subscribe with the following feed link:
http://nephjc.com/freelyfiltered?format=rss
Now with more realistic cover art
This visual abstract is by NSMC Intern, Mario Funes
Here is the visual abstract from The George Institue
